A vaccine against malaria has been shown to be highly effective in trials in Africa, holding out the real possibility of slashing the death toll of a disease that kills 400,000 mostly small children every year. The vaccine, developed by scientists at the Jenner Institute of Oxford University, showed up to 77% efficacy in a trial of 450 children in Burkina Faso over 12 months.
A major international study may spare thousands of women from getting treatments they do not need as it has been found that about 70% of women with early-stage breast cancer who could receive chemotherapy under current standards do not actually need it. The study found these women can skip chemotherapy and take an alternate estrogen-blocking drug.
The Food and Drug Administration approved the first generic version of EpiPen on Thursday in a move that may drive down the price of a life-saving product. The generic version made by Teva Pharmaceuticals USA will rival Mylan which has been criticized for high pricing. The exact launch date is not yet known.
The first government approval of a medication made from marijuana was supported unanimously by the Food and Drug Administration on Thursday. The drug called Epidiolex will be administered in syrup form and is made from cannabidiol (CBD) and would target the treatment of childhood Epilepsy. Full FDA agency clearance could occur by late June.
On Wednesday, the FDA approved a new groundbreaking treatment for sufferers of childhood leukemia which uses patients’ genetically altered immune cells to fight the disease. This marks a “historic” moment in medicine as this is the first gene-therapy to be approved in the U.S.